424B3: Prospectus
YS Biopharma | EFFECT: Others
YS Biopharma | 424B3: Prospectus
YS Biopharma | 424B3: Prospectus
YS Biopharma | 424B3: Prospectus
YS Biopharma | 424B3: Prospectus
YS Biopharma | 424B3: Prospectus
YS Biopharma | EFFECT: Others
YS Biopharma | EFFECT: Others
YS Biopharma | 424B3: Prospectus
YS Biopharma | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Summit Healthcare Acquisition Corp | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
YS Biopharma | 424B3: Prospectus
YS Biopharma | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Summit Healthcare Acquisition Corp | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
YS Biopharma | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Summit Healthcare Acquisition Corp | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
YS Biopharma | 424B3: Prospectus
YS Biopharma | EFFECT: Others
YS Biopharma | F-4/A: Registration statement for securities issued by foreign private issuers in certain business combination transactions (Amendment)
No Data
No Data